| Integrated Drug Discovery Services |
|
| Jubilant’s Drug Discovery and Development Services (DDDS) business offers integrated services across Target Validation, Discovery, Preclinical and Clinical Development and therapeutic areas of Oncology, Metabolic Diseases, Central Nervous System (CNS) and Infectious Diseases. |
|
| Our Target to Candidate integrated discovery services are offered across target platforms of Kinases, GPCRs, Ion Channels and Proteases etc. |
|
 |
| Click here to enlarge image |
|
| Jubilant DDDS business constitutes three Jubilant subsidiaries, Jubilant Biosys, Jubilant Chemsys and Jubilant Clinsys. With over 1000 highly skilled and experienced scientific and medical personnel spread across Bangalore and Noida in India, Europe and the US, the DDDS vertical leverages the capabilities in emerging markets for a global outcome, accelerating the global drug development efforts. |
|
|
|
